Featured · Drug Pricing
Chris Snyder Discusses FDA Drug Repurposing and Market Incentives
In the latest episode of the Health Policy Podcast, Christopher Snyder, a professor at Dartmouth College, discusses the FDA's exploration of drug repurposing and the economic incentives surrounding it. Snyder explains how generic drugs often miss opportunities for secondary uses due to a lack of financial motivation for manufacturers after patent expiration. He also highlights the work of the Market Shaping Accelerator, a collaborative initiative aimed at enhancing innovation in public health and addressing market failures.
2026-08-20 · with Christopher (Chris) Snyder
